GC4702

· Galera Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC4702, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers [Phase 1]

See pricing